MORGAN STANLEY - 28 Feb 2026 SCHEDULE 13G/A Report for X4 Pharmaceuticals, Inc Common Stock (XFOR)

Filing Manager
MORGAN STANLEY
Reporting Manager
Morgan Stanley
Security
X4 Pharmaceuticals, Inc Common Stock
Symbol
XFOR
Shares outstanding
87,101,353 shares
Disclosed Ownership
8,884,338 shares
Ownership
10%
Form type
SCHEDULE 13G/A
Filing time
06 Mar 2026, 16:24:18 UTC
Date of event
28 Feb 2026
Previous filing
12 Feb 2026
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Morgan Stanley 10% 8,884,338 0 8,884,338 Claire Gordon Authorized Signatory, Morgan Stanley
Morgan Stanley Investment Management Inc. 10% 8,884,304 0 8,884,304 Deidre A. Downes Authorized Signatory, Morgan Stanley Investment Management Inc.
Inception Trust 5.2% 4,518,236 0 4,518,236 Deidre A. Downes Authorized Signatory, Inception Trust